An Updated Meta-analysis of Pancreatic Cancer Risk in Patients with Inflammatory Bowel Disease [0.03%]
溃疡性结肠炎和克罗恩病患者胰腺癌风险的meta分析更新
Amir Mohammad Salehi,Shayan Bahadivand Chegini,Sara Danaei et al.
Amir Mohammad Salehi et al.
Objective: This meta-analysis aims to systematically evaluate the relationship between inflammatory bowel disease (IBD) and the risk of developing pancreatic cancer (PC). ...
Patient-Reported Outcomes During Neoadjuvant Therapy for Gastrointestinal Cancer and Their Association with Postoperative Complications [0.03%]
新辅助治疗期间胃肠肿瘤患者的症状自我报告及其与术后并发症的关系
Alexander H Shannon,Samantha M Ruff,Marilly Palettas et al.
Alexander H Shannon et al.
Purpose: Neoadjuvant therapy (NT) given before surgery for gastrointestinal (GI) malignancies can lead to adverse events. Whether patient-reported outcomes (PRO) or quality of life (QOL) during NT is predictive of postope...
Role of Neoadjuvant Therapy for Patients with Adenosquamous Carcinoma of the Pancreas: Outcomes from the National Cancer Database [0.03%]
新辅助治疗在胰腺导管腺鳞癌患者中的作用：来自国家癌症数据库的结果分析
Amanda K Walsh,Diamantis I Tsilimigras,Alex B Blair et al.
Amanda K Walsh et al.
Purpose: Pancreatic adenosquamous carcinoma (PASC) is a rare and aggressive form of pancreatic cancer whose management often follows its more common pancreatic ductal adenocarcinoma (PDAC) counterpart. While neoadjuvant t...
Identification of Patients with Early-Stage Hepatocellular Carcinoma Benefiting from Neoadjuvant Chemotherapy-A SEER-Based Study [0.03%]
基于SEER数据库的 neo化疗受益的早期肝癌患者筛选标志物的探索性研究
Shigang Xu,Liwei Duan,William C Cho et al.
Shigang Xu et al.
Background: The effectiveness of neoadjuvant chemotherapy (NAC) for individuals with early-stage hepatocellular carcinoma (HCC) is still a subject of controversy and uncertainty. This study sought to create a risk categor...
Pretreatment Skeletal Muscle Index and Survival Outcomes in Non-Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis [0.03%]
术前骨骼肌指数与非转移性结直肠癌患者的生存结局：系统评价和Meta分析
Clifford Atuiri,Isaac Che Ngang,Daniel Appiah et al.
Clifford Atuiri et al.
Background: Skeletal muscle index (SMI), a measure of muscle mass derived from pretreatment imaging, has emerged as a potential prognostic factor in cancer. Its role in non-metastatic colorectal cancer (CRC), where curati...
Final Results of ERBIMOX: A Randomized Phase II Study of Modified FOLFOX7 With or Without Cetuximab as First-Line Treatment for KRAS Wild-type Metastatic Colorectal Cancer [0.03%]
ERBIMOX最终研究结果：改良FOLFOX7联合或不联合西妥昔单抗作为野生型KRAS转移性结直肠癌一线治疗的II期随机临床试验
Karin Potthoff,Norbert Marschner,Lothar Müller et al.
Karin Potthoff et al.
Background: The combination of FOLFOX/FOLFIRI with an EGFR-antibody (cetuximab/panitumumab) is a first-line standard for RAS wild-type metastatic colorectal cancer (mCRC). The OPTIMOX stop-and-go regimen, which reduces ox...
Adjuvant Chemotherapy for Gastric Cancer may Worsen Prognosis in Elderly Women: Retrospective Analysis of Individual Patient Data from the CLASSIC Study [0.03%]
术前化疗可能恶化老年女性胃癌预后——CLASSIC研究个体患者数据的回顾性分析
Fumitaka Noji,Hideki Yoshioka,Ryota Jin et al.
Fumitaka Noji et al.
Purpose: This research aimed to identify significant prognostic factors that interact with the treatment effect of capecitabine and oxaliplatin (CapeOX), based on individual patient data from the CLASSIC study (NCT0041122...
Mixed Neuroendocrine and Non-neuroendocrine Tumor of Pancreato-Biliary Origin Treated Successfully with Peptide Receptor Radionuclide Therapy [0.03%]
一种混合型胰胆神经内分泌肿瘤成功采用肽受体放射性核素治疗的病例报告
Kalyan Mansukhbhai Shekhda,Tu Vinh Luong,Daniel Krell et al.
Kalyan Mansukhbhai Shekhda et al.
Purpose: Mixed neuroendocrine and non-neuroendocrine neoplasms (MiNENs) are rare neoplasms composed of morphologically distinguishable neuroendocrine (NE) and non-neuroendocrine components, each representing at least 30% ...
Comprehensive Bibliometric Analysis of Prediction Models for HCC: Current Trends and Future Prospects [0.03%]
肝细胞癌预测模型的综合文献计量分析：当前趋势与未来前景
Dong Li,Jingchao Sun,Xifeng Fu et al.
Dong Li et al.
Background: Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor, with rising incidence and mortality rates posing a significant threat to global public health. Accurate prediction of liver canc...
Rising Incidence of Total and Early-Onset Colorectal Cancer: A Global Perspective on Burden, Risk Factors, and Projections to 2031 [0.03%]
全球视角下的结直肠癌和早发型结直肠癌负担、风险因素及至2031年的预测报告
Jia-Xin Nie,Qin Xie,Yan Yuan et al.
Jia-Xin Nie et al.
Background: The occurrence of colorectal cancer in those under 50 has significantly increased in recent decades. This study assesses the burden of colorectal cancer (CRC) and early-onset colorectal cancer (EO-CRC), along ...